| NCAIM Number | B.02062 |
|---|---|
| Other Collection Number | CCM 4533, ATCC 10541, CCTM La 3776, CCUG 32258, CIP 58.55, CNCTC Str. 6/58, DSMZ 3320, FDA M 19, LMG 10274, NCIMB 8192, PCI 1341, |
| Strain Name | |
| Mutant | |
| Strain Status | |
| Strain History | |
| Previous Name | |
| Typestrain of | |
| Depositor | |
| Isolator | |
| Isolation source | |
| Isolation Type | |
| Restriction | Hazard Group 2 |
| Name of Medium | NCAIM 0032 - Brain Heart Infusion Agar 37°C |
| Notes and applications |
assay of gramicidin, thiostrepton, tyrothricin (British Pharmacopoeia Commission. Biological assay of antibiotics. In: British Pharmacopoeia 1993. Addendum 1: London (UK): British Pharmacopoeia Commission; 1995, Appendix XIV A, p. A403.; European Pharmacopoeia Commission. Microbiological assay of antibiotics. In: European Pharmacopoeia. 3rd ed. Strasbourg, France: European Pharmacopoeia Commission; 1997, EP 2.7.2.; US Food & Drug Administration. Microbiological assay methods. Code of Federal Regulations Title 21: Part 436, Subpart D.; U.S. Pharmacopeia. Antibiotics--microbial assays. In: U.S. Pharmacopeia. 23rd rev. Rockville, MD: U.S. Pharmacopeia; 1995, <81>, pp. 1690-1696.) ID checked by 16S sequencing |
| Literature |